BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Lecheng, MSD vow to deepen medical cooperation

The group engaged in investment and negotiations with 34 domestic and foreign pharmaceutical enterprises in such areas as the establishment of an industria...

November 13, 2023 | News

Eccogene and AstraZeneca Partner on ECC5004 for Cardiometabolic Diseases

Eccogene will receive initial upfront payment of $185 million. Eccogene is also eligible to receive up to $1.825 billion in future clinical,...

November 10, 2023 | News

Porton Advanced Partners with BioMap to Boost AAV Gene Therapy with AI Models

The goal is to harness the power of large-scale life science models, accelerating the design of AAV vectors, and expanding the application of AI models in ...

November 09, 2023 | News

KN026 was Granted Breakthrough Therapy Designation by CDE

Gastric cancer is one of the most common gastrointestinal malignancies in the world, and the number of new cases and deaths of gastric cancer in China...

November 08, 2023 | News

BioRay Starts Phase I Study for BRY812, Targeted Antibody Drug Conjugate

LIV-1, also known as SLC39A6 or ZIP6, is a multipass transmembrane protein belonging to the ZIP superfamily of zinc transporters, possesses zinc trans...

November 08, 2023 | News

Biotheus Partners with BioNTech to Develop Bispecific Antibody Targeting PD-L1 and VEGF in Solid Tumors

BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China Biotheus Inc. ("Biotheus"),...

November 07, 2023 | News

Sanyou Bio Cheers KangaBio's IND Approval for Next-Gen IL-12 Prodrug Cancer Immunotherapy

These trials will primarily focus on late-stage solid tumors and the effectiveness will either be evaluated as a standalone therapy or in combination with ...

November 06, 2023 | News

XtalPi and CK Life Sciences Partner to Develop AI-Based Cancer Diagnostic Models

With the help of AI and machine learning models, this collaborative engagement will hopefully lead to the development of more advanced and intelligent solu...

November 06, 2023 | News

Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

The company can initiate a project on four continents and easily transfer validated methods across labs, allowing therapeutic trials to extend to virtually...

November 03, 2023 | News

CStone Partners with 3SBio for Nofazinlimab in China

CStone to grant 3SBio exclusive rights for the development, registration, manufacturing, and commercialization of nofazinlimab (anti-PD-1 antibody) in ma...

November 02, 2023 | News

Rational Vaccines and Shenzhen Mellow Hope Partner on Herpes Vaccines in China

Rational Vaccines (RVx) and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (MH) announced they have reached an agreement to jointly develop, manufacture, ...

October 31, 2023 | News

First Patient Enrolled in Phase III Trial of Boan Biotech's Nivolumab

Nivolumab is a monoclonal antibody that can enhance the immune response of T cells against tumors by preventing the programmed cell death 1 (PD-1) receptor...

October 31, 2023 | News

Merck Expands Oncology Pipeline with Hengrui Partnership for PARP1 Inhibitor and ADC

Collaboration to develop, manufacture and commercialize next-generation selective PARP1 inhibitor HRS-1167, with option to develop, manufacture and comme...

October 31, 2023 | News

Chime Biologics and Hope Medicine Accelerate First-in-Class Antibody Drug HMI-115 for Endometriosis and Androgenic Alopecia

Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services for Hope Medicine...

October 27, 2023 | News

Stay Connected